TrialAnnals of the rheumatic diseases2020

Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis.

Masataka Kuwana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.